# OnCo record ucsd-moores (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/ucsd-moores/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "ucsd-moores" ;
  schema:name "UC San Diego Moores Cancer Center"@en ;
  schema:alternateName "Moores Comprehensive Cancer Center"@en ;
  schema:description "San Diego's NCI comprehensive cancer centre, where the anti-GD2 antibody dinutuximab and the ROR1 antibody behind zilovertamab were developed."@en ;
  schema:url <https://onco.cc/institutions/ucsd-moores/>, <https://moorescancercenter.ucsd.edu> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://moorescancercenter.ucsd.edu>, <https://clinicaltrials.ucsd.edu> ;
  schema:addressCountry "US" ;
  schema:addressLocality "La Jolla, CA" ;
  schema:latitude "32.877"^^xsd:decimal ;
  schema:longitude "-117.223"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/gd2/>, <https://onco.cc/targets/ror1/> ;
  onco:drugs <https://onco.cc/drugs/dinutuximab/>, <https://onco.cc/drugs/zilovertamab-vedotin/> ;
  onco:companies <https://onco.cc/companies/childrens-oncology-group/> ;
  onco:people <https://onco.cc/people/alice-yu/>, <https://onco.cc/people/diane-simeone/>, <https://onco.cc/people/rana-mckay/>, <https://onco.cc/people/j-silvio-gutkind/>, <https://onco.cc/people/ramez-eskander/>, <https://onco.cc/people/ezra-cohen/>, <https://onco.cc/people/ludmil-alexandrov/> .